Treatment of HIV-Related Fatigue with Armodafinil: A Placebo-Controlled Randomized Trial

Psychosomatics

Volumn 52, Issue 4, 2011, Pages 328-336

  Rabkin, Judith G ^a   McElhiney, Martin C ^a   Rabkin, Richard ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARMODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; MODAFINIL;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR; CD4 LYMPHOCYTE COUNT; CELL ASSAY; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENERGY; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NERVOUSNESS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADULT; AGED; BENZHYDRYL COMPOUNDS; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856391870     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2011.02.005     Document Type: Article

References (41)

1. Jong E., Oudhoff L., Epskamp C., et al. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral era. AIDS 2010, 24:1387-1405.
2. Barroso J., Hammill B., Leserman J., et al. Physiological and psychosocial factors that predict HIV related fatigue. AIDS Behav 2010, 14:1415-1427.
3. Paddison J., Fricchione G., Gandhi R., et al. Fatigue in psychiatric HIV patients: A pilot study of psychological correlates. Psychosomatics 2009, 50:455-460.
4. Duran S., Spire B., Raffi F., et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001, 2:38-45.
5. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington, DC. 4th ed.
6. Barroso J., Carlson J., Meynell J. Physiological and psychological markers associated with HIV-related fatigue. Clin Nurs Res 2003, 12:49-68.
7. Millikin C., Rourke S., Halman M., et al. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol 2003, 25:201-215.
8. Rabkin J.G. HIV and depression: 2008 review and update. Current HIV/AIDS Reports 2008, 5:163-171.
9. Jasinski D.R., Kovacevic-Ristanovic R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 2000, 23:149-156.
10. Darwish M., Kirby M., Robertson P., et al. Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4, and 2C19 in healthy subjects. Clin Pharmacokinet 2008, 47:61-74.
11. Winder-Rhodes S.E., Chamberlain S.R., Idris M.I., et al. Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers. J Psychopharm 2010, 24:1649-1657.
12. Ballon J., Feifel D. A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry 2006, 67:554-566.
13. Young J., Geyer M. Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors?. Biol Psychiatry 2010, 67:784-787.
14. Spathis A., Dhillan R., Booden D., et al. Modafinil for the treatment of fatigue in lung cancer: A pilot study. Palliative Med 2009, 23:325-331.
15. Brown J., Howard C., Kemp D. Modafinil for the treatment of multiple sclerosis-related fatigue (review article). Ann Pharmacother 2010, 44:1098-1103.
16. Rabkin J.G., Gordon P.H., McElhiney M., et al. Modafinil treatment of fatigue in patients with ALS: A placebo controlled study. Muscle Nerve 2009, 39:297-303.
17. Menza M., Kaufman K., Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000, 61:378-381.
18. DeBattista C., Doghramji K., Menza M., et al. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003, 64:1057-1064. Modafinil in Depression Study Group.
19. Krystal A., Harsh J., Yang R., et al. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. J Clin Psychiatry 2010, 71:32-40.
20. Calabrese J., Ketter T., Youakim J., et al. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double blind, placebo-controlled, proof of concept study. J Clin Psychiatry 2010, 71:1363-1370.
21. Rabkin J.G., McElhiney M., Rabkin R., et al. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo controlled study. J Clin Psychiatry 2010, 71:707-715.
22. First M.B., Spitzer R., Gibbon M., et al. User Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders 1996, American Psychiatric Association, Washington, DC, SCID.
23. Guy W. Clinical Global Impressions (CGI) Scale. Handbook of Psychiatric Measures 2008, 90-92. American Psychiatric Publishing, Washington, DC. 2nd ed. A. Rush, M. First, D. Blacker (Eds.).
24. Krupp L., LaRocca N., Muir-Nash J., et al. The Fatigue Severity Scale. Arch Neurol 1989, 46:1121-1123.
25. Whitehead L. The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage 2009, 37:107-128.
26. Johns M. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991, 14:540-545.
27. Handbook of Psychiatric Measures 2008, 116-117. American Psychiatric Publishing, Washington, DC. 2nd ed. A.J. Rush, M. First, D. Blacker (Eds.).
28. Chalder T., Berelowitz G., Pawlowska T., et al. Development of a fatigue scale. J Psychosom Res 1993, 37:147-153.
29. Williams J.B.W. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988, 45:742-747.
30. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory-II Manual 1996, Psychological Corp, San Antonio, TX.
31. Rabkin J.G., Markowitz J., Ocepek-Welikson K., et al. General vs. systematic inquiry about emergent clinical events with SAFTEE: Implications for clinical research. J Clin Psychopharmacol 1992, 12:3-10.
32. Maj M., D'Elia L., Satz P., et al. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: The WHO Study. Arch Clin Neuropsychol 1993, 8:123-135.
33. Wechsler D. Wechsler Adult Intelligence Scale 1997, (WAIS-III), The Psychological Corp, San Antonio, TX. 3rd ed.
34. D'Elia L., Satz P., Uchiyama C., et al. Psychological Assessment. Color Trails Test 1996, Resources, Inc., Odessa, FL.
35. Golden C.J. Stroop Word and Color Test: a manual for clinical and experimental uses 1978, Stoetling Co, Chicago, IL.
36. Matthews C., Klove H. Instruction Manual for the Adult Neuropsychology Test Battery 1964, University of Wisconsin Medical School, Madison, WI.
37. Neuropsychological Assessment 2004, 519-520. Oxford University Press, New York, NY. 4th ed. A.L. Benton, M. Lezak, D. Howieson (Eds.).
38. Miller E.N. California Computerized Assessment Battery (CalCAP) Manual 1990, Norland Software, Los Angeles, CA.
39. Antinori A., Arendt G., Becker J., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799.
40. McQuay H.J., Moore R.A. Using numerical results from systematic reviews in clinical practice. Ann Internal Med 1997, 126:712-720.
41. Volkow N., Fowler J., Logan J., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain. JAMA 2009, 301:1148-1154.